INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Journal website Submission website

Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.

Journal Title

INT J IMMUNOPATH PH

ISSN / eISSN

0394-6320 / 2058-7384

Aims and Scope

International Journal of Immunopathology and Pharmacology is an Open Access peer-reviewed journal publishing original papers describing research in the fields of immunology, pathology and pharmacology. The intention is that the journal should reflect both the experimental and clinical aspects of immunology as well as advances in the understanding of the pathology and pharmacology of the immune system.

Subject Area

PATHOLOGY

PHARMACOLOGY & PHARMACY

IMMUNOLOGY

CiteScore

3.40

View Trend

CiteScore Ranking

Category	Quartile	Rank
Pharmacology, Toxicology and Pharmaceutics - Pharmacology	Q3	#183/301
Pharmacology, Toxicology and Pharmaceutics - Immunology and Allergy	Q3	#144/211
Pharmacology, Toxicology and Pharmaceutics - Immunology	Q3	#162/217

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2023)	Quartile
IMMUNOLOGY - SCIE	Q3
PATHOLOGY - SCIE	Q2
PHARMACOLOGY & PHARMACY - SCIE	Q2

H-index

Country/Area of Publication

ITALY

Publisher

SAGE Publications Inc.

Publication Frequency

Quarterly

Year Publication Started

1988

Annual Article Volume

Open Access

YES

Contact

BIOLIFE SAS, VIA S STEFANO 39 BIS, SILVA MARINA (TE), ITALY, 64029

Popular journals in the same field
Recent articles

Novel anti-amyloid-beta (Aβ) monoclonal antibody lecanemab for Alzheimer’s disease: A systematic review: (2023) Selia Chowdhury, Nurjahan Shipa Chowdhury

Inhibition of GPR30 sensitized gefitinib to NSCLC cells via regulation of epithelial-mesenchymal transition: (2023) Xiaomin Yang, Hongyan Jiang, Jiang Ning, Shufen Zhang, Ying Cai, Liang Wang, Jinsong Yang, Guodong Xu, Wei Chen, Jianfei Wang

Analysis of mitochondrial function in lymphocytes obtained from COVID-19 patients: (2023) Zhi He, Jing-Jing Liu, Shao-Lei Ma

PKNOX1 acts as a transcription factor of DHH and promotes the progression of stomach adenocarcinoma by regulating the Hedgehog signalling pathway: (2023) Bing Liu, Siwei Zhao, Liqing Liu

The impact of hepatitis B virus and hepatitis C virus infections in patients with Hodgkin's and non-Hodgkin’s lymphoma: (2023) Dalia Y Kadry, Mostafa A Elbahnasawy, Mohamed TM Mansour, Omnia K EL Gebaly, Hala Aziz, Mahmoud M Kamel, Ahmed S Abdel-Moneim, Samah Radwan

Association of cerebrospinal fluid CD4+/CD8+Ratio with 60-day functional outcome after intracerebral hemorrhage: (2023) Chunying Zhu, Wei Li, Yingfu Zhang, Qianqian Li, Huan Wang

Revolutionizing antiretroviral therapy for human immunodeficiency virus/AIDS: A computational approach using molecular docking, virtual screening, and 3D pharmacophore building to address therapeutic failure and propose highly effective candidates: (2023) Azzeddine Annan, Noureddine Raiss, El Harti Elmir, Abdelkarim Filali-Maltouf, Leila Medraoui, Hicham Oumzil

Follow the time course of inflammation caused by intraperitoneal administration of multi-wall carbon nanotubes in mice: (2023) Masanori Horie, Sakiko Sugino, Tomoki Ohno

Prognostic and immunological role of acetaldehyde dehydrogenase 1B1 in human tumors: A pan-cancer analysis: (2023) Yong Kuang, Jiahao Feng, Yuhong Jiang, Qianqian Jin, Qi Wang, Changhua Zhang, Yulong He

METTL3-mediated m6A modification of lncRNA SNHG3 accelerates gastric cancer progression by modulating miR-186-5p/cyclinD2 axis: (2023) Guo Ji, Xiu Wang, Hao Xi

Verified Reviews

Note: Verified reviews are sourced from across review platforms and social media globally.

One of our classmates in the laboratory received a solicitation from the editor of this magazine in December. Coincidentally, he had an article at hand, so he made some modifications and submitted it. The magazine responded quite quickly as the next day, the article on their official website changed from "editorial solicitation" to "peer review." Ten days later, we received a rejection letter stating that the magazine had received many submissions and our overall article quality was not high. Hmm... This magazine was on the warning list in January 2020 but came off the list in December. This may be a result of their strict and high requirements.

2022-01-13

View All Reviews

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started